Abstract
How would immune reconstitution gone wrong as a consequence of treatment be detected when the patient received a transplant to treat an autoimmune disorder? The article by Daikeler et al in this issue of Blood demonstrates how complicated this question might be.
Cite
CITATION STYLE
APA
Pavletic, S. Z. (2011, August 11). HSCT for AID: Entering prime time? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-06-356576
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free